IRHYTHM TECH (NASDAQ:IRTC) EVP David A. Vort sold 5,000 shares of IRHYTHM TECH stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $48.76, for a total value of $243,800.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

IRHYTHM TECH (IRTC) opened at 49.04 on Friday. The firm’s market capitalization is $1.11 billion. The firm’s 50-day moving average price is $49.19 and its 200 day moving average price is $43.37. IRHYTHM TECH has a one year low of $22.16 and a one year high of $50.51.

IRHYTHM TECH (NASDAQ:IRTC) last posted its earnings results on Wednesday, August 2nd. The company reported ($0.29) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.31) by $0.02. The company had revenue of $23.85 million during the quarter, compared to analyst estimates of $22.10 million. IRHYTHM TECH had a negative net margin of 27.34% and a negative return on equity of 57.23%. The firm’s quarterly revenue was up 51.6% on a year-over-year basis. On average, equities analysts anticipate that IRHYTHM TECH will post ($1.13) earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “David A. Vort Sells 5,000 Shares of IRHYTHM TECH (IRTC) Stock” was published by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at

Several institutional investors have recently bought and sold shares of the company. Nationwide Fund Advisors boosted its holdings in shares of IRHYTHM TECH by 30.2% during the first quarter. Nationwide Fund Advisors now owns 4,069 shares of the company’s stock worth $153,000 after purchasing an additional 945 shares during the period. Legal & General Group Plc lifted its holdings in IRHYTHM TECH by 131.0% in the second quarter. Legal & General Group Plc now owns 3,373 shares of the company’s stock worth $143,000 after buying an additional 1,913 shares during the period. Bank of New York Mellon Corp lifted its holdings in IRHYTHM TECH by 20.9% in the first quarter. Bank of New York Mellon Corp now owns 21,664 shares of the company’s stock worth $814,000 after buying an additional 3,743 shares during the period. EAM Investors LLC lifted its holdings in IRHYTHM TECH by 19.7% in the second quarter. EAM Investors LLC now owns 24,942 shares of the company’s stock worth $1,060,000 after buying an additional 4,106 shares during the period. Finally, American International Group Inc. purchased a new stake in IRHYTHM TECH in the first quarter worth about $161,000. Institutional investors own 93.25% of the company’s stock.

IRTC has been the topic of several recent research reports. Morgan Stanley lifted their target price on IRHYTHM TECH from $43.00 to $47.00 and gave the stock an “overweight” rating in a report on Tuesday, June 6th. Canaccord Genuity reaffirmed a “buy” rating and set a $42.00 target price on shares of IRHYTHM TECH in a report on Tuesday, June 6th. Finally, Zacks Investment Research downgraded IRHYTHM TECH from a “hold” rating to a “sell” rating in a report on Wednesday, July 5th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. IRHYTHM TECH has an average rating of “Hold” and an average target price of $37.75.

IRHYTHM TECH Company Profile

iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.

Insider Buying and Selling by Quarter for IRHYTHM TECH (NASDAQ:IRTC)

Receive News & Ratings for IRHYTHM TECH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRHYTHM TECH and related companies with's FREE daily email newsletter.